Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Drug Review Head Is Jenkins, Ending 15-Month Search

This article was originally published in The Tan Sheet

Executive Summary

Office of Drug Evaluation II Director John Jenkins, MD, will take over as FDA's top drug review manager effective Jan. 2. The agency announced the appointment of Jenkins as Office of Review Management director in a staff memo Dec. 11

You may also be interested in...



FDA staffing

Sandra Kweder, MD, named ODE II acting director effective Jan. 13, filling post vacated by John Jenkins, MD, who is now Office of New Drugs director. Jenkins, Kweder essentially swapped roles, as Kweder was former acting director of Office of Review Management, now known as OND (1"The Tan Sheet" Dec. 17, 2001, p. 9)...

FDA staffing

Sandra Kweder, MD, named ODE II acting director effective Jan. 13, filling post vacated by John Jenkins, MD, who is now Office of New Drugs director. Jenkins, Kweder essentially swapped roles, as Kweder was former acting director of Office of Review Management, now known as OND (1"The Tan Sheet" Dec. 17, 2001, p. 9)...

FDA staffing

Sandra Kweder, MD, named ODE II acting director effective Jan. 13, filling post vacated by John Jenkins, MD, who is now Office of New Drugs director. Jenkins, Kweder essentially swapped roles, as Kweder was former acting director of Office of Review Management, now known as OND (1"The Tan Sheet" Dec. 17, 2001, p. 9)...

Related Content

Topics

UsernamePublicRestriction

Register

PS093392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel